The aim of the study was to evaluate electrocardiography and echocardiography in the diagnosis of familial hypertrophic cardiomyopathy in children, using the genetic status as the criterion of reference.
Introduction
Hypertrophic cardiomyopathy is a primary myocardial disease, often familial, and transmitted as an autosomal dominant trait [1, 2] . Penetrance of the disease, i.e. clinical expression of the morbid gene, is incomplete and agerelated [1] [2] [3] : left ventricular hypertrophy may develop or progress during childhood or adolescence [4, 5] . Identification of young individuals at risk of developing the disease later is therefore a key issue in familial hypertrophic cardiomyopathy. This clinical task is often difficult and pre-molecular studies have suggested that the ECG is more sensitive than echocardiography in identifying affected children [5] . The recent development of molecular genetics in familial hypertrophic cardiomyopathy provides the opportunity to reassess the value of conventional diagnostic criteria for the disease. Using the genetic status as the criterion of reference, the aim of the study was to evaluate the diagnostic value of the ECG and echocardiography for familial hypertrophic cardiomyopathy in children from families in which the causative mutation was identified. The first goal was to determine the percentage of genetically affected children identified by conventional criteria, and also to determine which examination was more accurate. The second goal was to progress towards the identification of healthy carriers of a mutation, children without hallmarks of the disease, such as left ventricular hypertrophy, by analysing the diagnostic value of additional diagnostic criteria in this particular population.
Methods

Population
Thirteen families with hypertrophic cardiomyopathy in which the causative mutation was identified were screened for inclusion in the study. After informed consent was obtained, clinical evaluation was performed and blood samples obtained. Genotypic assessment was determined and has been described elsewhere [6] [7] [8] [9] [10] . Thirty-five children (<18 years old) at risk of inheriting the disease gene were included. None of them had another possible cause of left ventricular hypertrophy (e.g. hypertension). Sixteen were genetically affected, seven were associated with a mutation in the betamyosin heavy chain gene (Arg403Leu: n=1; Arg723Cys: n=5; Glu930: n=1 [6, 7] ); seven were associated with a mutation in the cardiac myosin binding protein-C gene (SASint20: n=3; SDSint23: n=2; branch-point int23: n=1; Glu542Gln: n=1) [8, 9] and two were associated with a mutation in the myosin regulatory light chain gene in a family which exhibited a classical form of familial hypertrophic cardiomyopathy [10] . ECG and echocardiography were performed at the time of genotyping and were analysed independently by three observers, who had no knowledge of the genetic status.
Echographic procedure and criteria
Subjects underwent M-Mode, two-dimensional echocardiography and Doppler ultrasonography. End diastolic left ventricular wall thickness measurements in the M-mode were made according to the recommendations of the American Society of Echocardiography [11] . Hypertrophy was assessed from the parasternal shortaxis view, at both the mitral valve and papillary muscle levels and also from the parasternal long-axis view and the apical views. For each location, three consecutive measurements were made and averaged. The maximal wall thickness from any location was thus determined [12] . As previously described [5] , measurements were compared with available standards obtained in a normal population with an M-mode assessment [13] . Maximal wall thickness was considered as abnormal (=major echo criterion) if it exceeded the 95% predicted interval for age and body surface area. Concordant observations were made for all subjects. Other parameters, stratified according to age and body surface area when possible [13] , were studied and considered as minor abnormalities (see Appendix for listing and definitions).
Electrocardiographic procedure and criteria
Standard 12-lead ECGs were performed at the time of echocardiography with patients in the supine position during quiet respiration. Major abnormalities on the ECG were defined as previously described [5] . Q waves (criterion 1) were considered abnormal if depth was d3 mm or duration d0·04 s, and present in d2 leads. Q waves present only in V 1 and V 2 or only in lead III were not considered as abnormal. Voltages (criterion 2) were considered increased when the sum of the S wave in V 1 and the R wave in V 6 exceeded the 95th percentile stratified by age [14] . Repolarization alterations (criterion 3) were defined as marked T-wave inversions in at least two leads. Isolated T wave inversion in V 1 or V 2 or lead III was not considered abnormal. Major criteria for familial hypertrophic cardiomyopathy were defined by the presence of criterion (1) and/or (2) and/or (3). Additional criteria were analysed and considered as minor abnormalities (see Appendix for listing and definitions).
Statistical analyses
Sensitivity was defined (%) as true positives/(true positives+false negatives) 100; specificity as true negatives/(true negatives+false positives) 100; positive predictive value as true positives/(true positives+false positives) 100; negative predictive value as true negatives/(true negatives+false negatives) 100. Continuous data were expressed as mean standard deviation and were analysed with the unpaired, two-tailed t-test (or with the Mann-Whitney test). Discrete variables were expressed as a percentage and compared by chi square tests (or with the Fisher test). For all comparisons, differences were considered to be statistically significant when P<0·05.
Results
Population
Mean age and body surface area were similar in the 16 genetically affected children (G+ group) and in the 19 unaffected (G group) (11·0 3·3 years old vs 12·8 3·1; 1·26 m . m 2 0·28 vs 1·43 0·30 respectively, P>0·05 for both). There were 10 male individuals in the G+ group and nine in the G group. The mean value of the mean arterial pressure was slightly lower in the G+ group (67·5 mmHg 7 vs 75·4 8, P<0·01). Only two children presented symptoms (both atypical chest pain), one in the G and one in the G+ group. This latter child was the only one known to be clinically affected by familial hypertrophic cardiomyopathy at the time of the study and was the only one who received medical treatment (bisoprolol for 1 month). The other children were considered as clinically unaffected before the study, or had not been previously examined. At examination, a mild systolic murmur was observed in three of the G+ group (19%) and in two of the G group (10·5%). ECG recordings were all in sinus rhythm.
Diagnostic value of major criteria
The mean maximal wall thickness was 10·7 4·8 mm in the G+ group and 8·7 1·4 mm in the G group (difference not statistically significant). Values for each child are shown in Fig. 1 . The major echocardiographic criterion was found in 8/16 genetically affected children (50%) as compared to 6/16 (38%) who presented any of the major ECG criteria (increased QRS voltage: n=4, abnormal Q wave: n=2, abnormal negative T waves: n=1). In the G group, left ventricular maximal wall thickness was within the theoretical normal range in all subjects and no child had any of the major ECG criteria. In the subgroup of eight G+ children with an abnormal echocardiogram, the ECG was abnormal in only five subjects (62·5%). In the other eight G+ children with a normal echocardiogram, one had a typically abnormal ECG. In the subgroup of six G+ children with an abnormal ECG, the major echocardiographic criterion was found in five (83%). Conversely, in the 10 G+ subjects with a normal ECG, the echocardiogram was abnormal in three (30%). Major ECG or echocardiographic criteria were absent in 7/16 children (44%). The diagnostic values of the ECG and echocardiogram for familial hypertrophic cardiomyopathy are given in Table  1 . Regression analyses performed between QRS voltage (SV 1 +RV 6 ) and maximal wall thickness on echocardiography indicated a positive correlation in the G+ group (r=0·806, P= 0·0002, n=16).
Analysis of minor criteria
The diagnostic value of 22 minor additional ECG and echocardiographic minor criteria was analysed (list in Appendix and Table 2 =maximal theoretical values for each child. 
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significant gradient. Results of other criteria are indicated in Table 2 . The diagnostic value of each of these 22 criteria was analysed. We identified four minor criteria, arbitrarily considered as clinically useful because of a positive predictive value >80% : one on the ECG (left QRS axis deviation) and three on the echocardiogram (intraventricular septum/posterior wall ratio d1·3, increased left atrium dimension, E/A wave ratio <1). Diagnostic values are shown in Table 3 . In the absence of bundle branch block, left QRS axis deviation (>95th percentile) was very specific and useful as four of the five subjects with this criterion had no major ECG criterion. The most useful minor echocardiographic criterion was the intraventricular septum/posterior wall ratio (d1·3), because three of the five subjects with this criterion did not fulfil the major echocardiographic criterion. An increased left atrium dimension (>95th percentile) and/or a low E/A wave ratio (<1), were found in six subjects, of whom two had no left ventricular hypertrophy on the echocardiogram. The diagnostic values of the ECG and echocardiography, including these four additional minor criteria, are shown in Table 3 . The sensitivity of the ECG and echocardiography increased to 63% and 81%, respectively, while specificity remained high (100% and 95%, respectively). When the ECG and echocardiogram were combined, the positive predictive value and negative predictive value of major+minor criteria for the disease were both d90%.
Discussion
Reappraisal of the usual diagnostic criteria for familial hypertrophic cardiomyopathy, based on molecular genetics, is of particular importance in children at risk of inheriting the disease since the clinical marker of the disease, i. e. ventricular hypertrophy, may appear during late childhood or even adolescence [4] . Using the genetic status as the criterion of reference, we studied the diagnostic value of the ECG and echocardiogram for familial hypertrophic cardiomyopathy in genotyped children, in a similar approach to that recently performed in adults [15] . This approach appears particularly interesting since it provides a valid gold standard for the disease. Furthermore, it minimizes potential inclusion bias since all children involved in genetic studies were Mean value SD are indicated for continuous variables and absolute numbers for qualitative variables. IVS=interventricular septum (M-mode echocardiogram); PW=posterior wall (M-mode echocardiography); SAM=systolic anterior motion of the mitral valve. All comparisons between the two groups indicated no statistically significant differences.
included in this study, whatever their clinical status (previous clinical diagnosis or symptoms), whereas previous studies came from tertiary referral centres with highly selected populations. Indeed, only one of the 16 genetically affected children was known to be clinically affected at the start of our study. Initially, the study allowed us to assess the diagnostic value of conventional diagnostic criteria for the disease. Our results show that the specificity of major ECG and echocardiographic diagnostic criteria was excellent. No false-positives were found, although some genetically unaffected children had values close to the maximal theoretical values, especially for QRS voltage on the ECG or maximal wall thickness on the echocardiogram. Subsequently, we found that the sensitivity of these major criteria was relatively poor: only 56% of genetically affected children were diagnosed on the basis of a major ECG and/or echocardiographic criterion. The number of children considered as 'healthy' carriers of a mutation was therefore high (44%) in our population.
We found that the sensitivity of echocardiography was better than that of the ECG (50% vs 38% for major criteria). In addition, the ECG could remain normal even when the echocardiogram is registering an abnormal result (three subjects). These findings are in contrast with pre-molecular studies which suggested that the ECG was more sensitive than echocardiography in children [5] . A group of 38 children followed by Panza et al., all presented with left ventricular hypertrophy on echocardiography at the most recent evaluation. However, at the first examination, seven children did not have left ventricular hypertrophy but they already demonstrated significant ECG abnormalities [5] . The mean age at the first examination in this latter study was similar to that in our study. Although echocardiography appears in our study as a more accurate diagnostic tool than the ECG for familial hypertrophic cardiomyopathy, it should be emphasized that the degree of hypertrophy found in affected subjects was often mild. Assessment of echocardiographic diagnosis in children therefore requires an experienced and meticulous echocardiographist, but the quality of the recordings in children is usually better than that in adults, allowing more accurate measurements.
Due to the relatively poor sensitivity of the major criteria mentioned above, we searched for additional helpful diagnostic criteria. Twenty-two different criteria were analysed. These criteria characterized cardiac abnormalities which are sometimes described in familial hypertrophic cardiomyopathy with overt left ventricular hypertrophy but which are usually considered as non specific. Moreover, their diagnostic value in the absence of left ventricular hypertrophy was unknown. Most of these criteria were of little interest because of numerous false positives or because of a very poor sensitivity. However, four criteria were identified as really useful because of their good diagnostic value and because they were often abnormal even when major criteria were absent. Interestingly, the sensitivity of the ECG or echocardiogram was greatly improved without altering specificity. Again, the echocardiogram was more sensitive than the ECG. Finally, when the ECG and echocardiogram were used together, and when the four minor criteria were taken into account, most of the apparently healthy carriers of a mutation (based on conventional criteria) were identified, so that 90% of children were correctly diagnosed. These findings may therefore have important implications for the screening of children in familial hypertrophic cardiomyopathy families and for genetic counselling. When a child does not fulfil any of the major or minor criteria defined above (see Table 3 ), then the probability of being genetically affected appears very uncommon. Conversely, when a child does fulfil one of the four minor criteria, even in the absence of left ventricular hypertrophy on the echocardiogram or major criteria on the ECG, then he/she should be considered as genetically affected, and specific investigations should be performed and specific care proposed.
Study limitations
The number of children studied here is limited. Our results should therefore be considered as preliminary and should be confirmed in larger studies of more subjects. We could not analyse the diagnostic value according to the gene or mutation involved since the size of the subgroups was too small. Finally, results are valid only in the age group studied here, and only in the familial form of hypertrophic cardiomyopathy.
